ATG10 is abnormally overexpressed in multiple cancers, including gastric cancer, colorectal cancer and acute leukemia, and its overexpression is strongly associated with poor prognosis and adverse clinicopathological features. This evidence concerns the gene ATG10 and acute leukemia.